Gastrointestinal Stent Market
Gastrointestinal Stent Market Size, Share & Trends Analysis Report by Product Type (Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, Esophageal Stent), By Technology Type (Anti Migratory Stent, Drug Eluting Stent, Radioactive Stent, Anti Reflux Stent, and Shape Modified Stent), By Material (Plastic Stent, Self-Expanding Metal Stent, Covered Self Expandable Metallic Stent, Biodegradable or Drug Eluting Stent) And By End-User (Hospital, Specialty Clinic and Ambulatory Surgical Center), Forecast Period (2026-2035)
Industry Overview
Gastrointestinal stent market was valued at $540.2 billion in 2025 and is projected to reach $892.3 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026-2035). The global gastrointestinal stent market is experiencing consistent growth, driven by the increasing incidence of gastrointestinal disorders, including malignant and benign obstructions. Rising preference for minimally invasive procedures has led to greater utilization of gastrointestinal stents across hospitals and specialty clinics. Continuous advancements in stent technologies, such as improved material composition and enhanced anti-migratory features, have strengthened clinical outcomes and procedural efficiency. The growing elderly population, which is more prone to gastrointestinal complications, has further contributed to sustained market demand. Expansion of healthcare infrastructure and improved access to advanced endoscopic treatments in developing regions are also supporting market growth. Additionally, heightened awareness among healthcare professionals regarding early intervention and effective disease management continues to positively influence the market outlook during the forecast period.
Market Dynamics
Rising Adoption of Minimally Invasive Endoscopic Procedures
The increasing preference for minimally invasive endoscopic procedures has emerged as a key trend in the gastrointestinal stent market, driven by their ability to minimize surgical trauma and shorten hospital stays. These procedures offer faster recovery, reduced post-operative complications, and improved overall patient quality of life when compared to traditional surgical approaches. As a result, healthcare providers are increasingly incorporating stent-based interventions into routine clinical practice for managing gastrointestinal obstructions. Technological improvements in endoscopic imaging and navigation have further enhanced procedural accuracy and success rates. The growing shift toward outpatient care has also supported the use of endoscopic stenting in ambulatory surgical centers. Additionally, rising healthcare cost containment efforts are encouraging the adoption of minimally invasive treatments. This trend is expected to continue as clinical guidelines increasingly favor less invasive therapeutic options.
Advancements in Stent Technology and Materials
Ongoing advancements in stent technology and material composition represent a significant trend shaping the gastrointestinal stent market. Manufacturers are focusing on developing drug-eluting, anti-migratory, and biodegradable stents to improve therapeutic effectiveness and reduce procedure-related complications. Enhanced material properties, such as increased radial strength, flexibility, and corrosion resistance, have contributed to improved stent performance and durability. Innovations in coating technologies have also helped reduce tissue irritation and infection risks. These developments are expanding the range of clinical applications for gastrointestinal stents across different disease conditions. Furthermore, improved biocompatibility has led to higher physician confidence and broader patient acceptance. As research and development activities continue, technological progress is expected to further drive market growth.
Market Segmentation
- Based on the product type the market is segmented into biliary stent, duodenal stent, colonic stent, pancreatic stent, esophageal stent.
- Based on the distribution channel the market is segmented into anti migratory stent, drug eluting stent, radioactive stent, anti-reflux stent, and shape modified stent.
- Based on the material the market is segmented into plastic stent, self-expanding metal stent, covered self-expandable metallic stent, biodegradable or drug eluting stent.
- Based on the end-user (hospital, specialty clinic and ambulatory surgical center)
Biliary Stents as a Primary Contributor to Market Revenue
Biliary stents account for the largest share within the product type segment, driven by their widespread use in managing bile duct obstructions associated with gallstones, strictures, and hepatobiliary malignancies. The high global incidence of pancreatic and cholangiocarcinoma has significantly increased procedural demand for biliary drainage interventions. Hospitals remain the primary end users due to the complexity of biliary conditions requiring advanced imaging and skilled endoscopic expertise. Key manufacturers such as Boston Scientific, Cook Medical, and Taewoong Medical continue to strengthen this segment through improved patency designs and infection-resistant coatings. Recent trends indicate a shift toward covered and anti-reflux biliary stents to reduce occlusion rates. Growing adoption of ERCP procedures is further sustaining volume growth. Continuous product upgrades remain critical to maintaining competitive positioning.
Biodegradable Stents Advancing High Growth Material Adoption
Biodegradable stents represent the fastest growing material sub-segment, primarily due to their clinical advantage of natural degradation without the need for secondary removal procedures. This material innovation is gaining momentum in temporary gastrointestinal applications, particularly for benign strictures and post-surgical support. Advances in bioresorbable polymers have improved structural reliability while minimizing inflammatory responses. Leading players are investing in research to combine biodegradability with drug-eluting capabilities, enhancing therapeutic effectiveness. Regulatory approvals and ongoing clinical evaluations are expanding acceptance across multiple indications. The trend toward patient-centric and minimally invasive care is accelerating adoption. Emerging healthcare markets are expected to play a pivotal role in sustaining this rapid growth trajectory.
Regional Outlook
The global gastrointestinal stent market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Maintaining Strong Clinical Demand and Innovation
North America continues to exhibit robust growth in the gastrointestinal stent market, driven by advanced healthcare infrastructure and high procedural volumes for complex gastrointestinal conditions. The presence of leading medical technology companies and early adoption of cutting?edge stent designs have reinforced regional leadership. Key players such as Boston Scientific, Cook Medical, and Medtronic are actively expanding their portfolios with improved anti?migration and drug?eluting features. Rising incidence of gastrointestinal cancers and related obstructions has increased clinical demand for both palliative and therapeutic stenting. Gastrointestinal (GI) cancers, including liver, colorectal, esophageal, stomach, and pancreatic cancers, are projected to rise in incidence and mortality over the next 20 years in the US, according to findings published in the American Journal of Gastroenterology. In 2024, GI cancers account for approximately 18% of all cancer cases and 28% of cancer-related fatalities in the US, representing a significant public health burden. Recent trends include greater utilization of minimally invasive endoscopic procedures and value-based care initiatives that emphasize improved patient outcomes.
Asia Pacific Emerging as a Rapidly Expanding Market
The Asia Pacific region is witnessing accelerated expansion in the gastrointestinal stent market, supported by improving healthcare infrastructure and rising awareness of interventional treatment options. Increasing incidence of gastrointestinal disorders and growing access to endoscopic services in markets such as China, India, and South Korea are key growth drivers. Local and international manufacturers are intensifying their presence through strategic partnerships and increased distribution networks. Recent trends show heightened adoption of advanced stents, including biodegradable and covered self?expandable metal designs, particularly in high?volume tertiary care centers. Government initiatives aimed at expanding insurance coverage and upgrading medical facilities are further propelling market uptake. The combination of demographic shifts and enhanced training of healthcare professionals is expected to sustain long?term regional growth.
Market Players Outlook
The major companies operating in the global Gastrointestinal Stent market include Boston Scientific Corp., Cook Medical LLC, Medtronic plc, Olympus Corp. and Taewoong Medical Co., Ltd., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In October 2025, Boston Scientific announced FDA 510(k) clearance and CE Mark approval for its Advanix Biliary Plastic Stents, designed for the treatment of benign and malignant biliary strictures. The stents, featuring the NaviFlex RX Delivery System for improved placement and repositioning, are now available in Europe with a U.S. launch planned, enhancing the company’s endoscopic stent portfolio.
- In July 2024, CGBIO received PMDA approval in Japan for its biliary stent ARISTENT, designed with a patented hook-and-cross structure and available in coated (CC) and uncoated (NC) variants to maintain bile duct patency. The approval marks the company’s first major gastrointestinal stent launch, with plans to expand its portfolio to esophagus, duodenum, and colon stents and enter global markets including the US and Europe.
- In May 2024, Abbott launched its XIENCE Sierra Everolimus Eluting Coronary Stent System in India, offering enhanced design, improved deliverability, and advanced features for treating complex coronary artery blockages. The stent aims to support interventional cardiologists in performing precise and effective percutaneous coronary interventions, addressing the rising prevalence of coronary artery disease in the country.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global gastrointestinal stent market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Gastrointestinal Stent Market Sales Analysis – Product Type| Technology Type |Material | End-User| ($ Million)
- Gastrointestinal Stent Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Gastrointestinal Stent Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Gastrointestinal Stent Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Gastrointestinal Stent Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Gastrointestinal Stent Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Gastrointestinal Stent Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Gastrointestinal Stent Market Revenue and Share by Manufacturers
- Gastrointestinal Stent Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Boston Scientific Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Cook Medical LLC
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Olympus Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Taewoong Medical Co., Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Boston Scientific Corp.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Global Gastrointestinal Stent Market Sales Analysis by Product Type ($ Million)
- Spray
- Roll-on
- Stick
- Others (Cream, Gel, Wipes)
- Global Gastrointestinal Stent Market Sales Analysis by Distribution Channel ($ Million)
- Supermarkets & Hypermarket
- Specialized Cosmetic Stores
- Online Channels
- Regional Analysis
- North American Gastrointestinal Stent Market Sales Analysis – Product Type| Technology Type |Material | End-User| Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Gastrointestinal Stent Market Sales Analysis – Product Type| Technology Type |Material | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Gastrointestinal Stent Market Sales Analysis – Product Type| Technology Type |Material | End-User| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and Other)
- Rest of Asia-Pacific
- Rest of the World Gastrointestinal Stent Market Sales Analysis – Product Type| Technology Type | Material | End-User| Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Boston Scientific Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BVM Medical Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Changzhou Health Microport Medical Devices Co., Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CONMED Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ELLA-CS, s.r.o.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Endo-Flex GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hobbs Medical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- I.Tech Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medico’s Hirata, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic Plc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merit Medical Systems, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Micro-Tech (Nanjing) Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Mitra Industries Pvt Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Olympus Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QualiMed Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- S&G Biotech, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Taewoong Medical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Taijin Medical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corp.
1. Global Gastrointestinal Stent Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global Biliary Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Duodenal Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Colonic Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Pancreatic Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Esophageal Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Gastrointestinal Stent Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
8. Global Anti-Migratory Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Drug Eluting Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Radioactive Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Anti-Reflux Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Gastrointestinal Stent Market Research and Analysis by Material, 2025–2035 ($ Million)
13. Global Plastic Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Self-Expanding Metal Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Covered Self-Expanding Metal Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Gastrointestinal Stent Market Research and Analysis by End-User, 2025–2035 ($ Million)
17. Global Gastrointestinal Stent For Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Gastrointestinal Stent For Specialty Clinic Market Research and Analysis by Region, 2025–2035 ($ Million)
19. Global Gastrointestinal Stent For Ambulatory Surgical Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Global Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
21. North American Gastrointestinal Stent Market Research and Analysis by Country, 2025–2035 ($ Million)
22. North American Gastrointestinal Stent Market Research and Analysis by Product Type, 2025–2035 ($ Million)
23. North American Gastrointestinal Stent Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
24. European Gastrointestinal Stent Market Research and Analysis by Country, 2025–2035 ($ Million)
25. European Gastrointestinal Stent Market Research and Analysis by Product Type, 2025–2035 ($ Million)
26. European Gastrointestinal Stent Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
27. Asia-Pacific Gastrointestinal Stent Market Research and Analysis by Country, 2025–2035 ($ Million)
28. Asia-Pacific Gastrointestinal Stent Market Research and Analysis by Product Type, 2025–2035 ($ Million)
29. Asia-Pacific Gastrointestinal Stent Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
30. Rest of the World Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
31. Rest of the World Gastrointestinal Stent Market Research and Analysis by Product Type, 2025–2035 ($ Million)
32. Rest of the World Gastrointestinal Stent Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
1. Global Gastrointestinal Stent Market Share by Product Type, 2025 Vs 2035 (%)
2. Global Biliary Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
3. Global Duodenal Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
4. Global Colonic Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
5. Global Pancreatic Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
6. Global Esophageal Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
7. Global Gastrointestinal Stent Market Share by Technology Type, 2025 Vs 2035 (%)
8. Global Anti-Migratory Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
9. Global Drug Eluting Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
10. Global Radioactive Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
11. Global Anti-Reflux Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
12. Global Gastrointestinal Stent Market Share by Material, 2025 Vs 2035 (%)
13. Global Plastic Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
14. Global Self-Expanding Metal Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
15. Global Covered Self-Expanding Metal Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
16. Global Gastrointestinal Stent Market Share by End-User, 2025 Vs 2035 (%)
17. Global Gastrointestinal Stent For Hospitals Market Share by Region, 2025 Vs 2035 (%)
18. Global Gastrointestinal Stent For Specialty Clinic Market Share by Region, 2025 Vs 2035 (%)
19. Global Gastrointestinal Stent For Ambulatory Surgical Centers Market Share by Region, 2025 Vs 2035 (%)
20. Global Gastrointestinal Stent Market Share by Region, 2025 Vs 2035 (%)
21. Global Gastrointestinal Stent Market Research and Analysis by Region, 2025–2035 ($ Million)
22. US Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
23. Canada Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
24. UK Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
25. France Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
26. Germany Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
27. Italy Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
28. Spain Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
29. Russia Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
30. Rest of Europe Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
31. India Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
32. China Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
33. Japan Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
34. South Korea Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
35. Australia and New Zealand Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
36. ASEAN Economies Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
37. Rest of Asia-Pacific Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
38. Latin America Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
39. Middle East and Africa Gastrointestinal Stent Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Gastrointestinal Stent Market in 2025 is estimated to be around $540.2 billion.
North America holds the largest share in the Gastrointestinal Stent Market.
Leading players in the Gastrointestinal Stent Market include Boston Scientific Corp., Cook Medical LLC, Medtronic plc, Olympus Corp. and Taewoong Medical Co., Ltd., among others.
The Gastrointestinal Stent Market is expected to grow at a CAGR of 5.2% from 2026 to 2035.
The Gastrointestinal Stent Market growth is driven by rising prevalence of gastrointestinal cancers and increasing adoption of minimally invasive endoscopic procedures.
